舒利迭治疗哮喘55例临床分析
摘要
我院自2002年以来采用舒利迭(沙美特罗50μg,替卡松250μg)粉吸剂治疗哮喘取得较好的效果,现报道如下。
出处
《中国现代医生》
2007年第08S期96-96,共1页
China Modern Doctor
二级参考文献11
-
1BARANIUK J N,ALI M,BRODY D,et al.Glucocorticoids induce beta2-adrenergic receptor function in human nasal mucosa[J].Am J Respir Crit Care Med,1997,155:704-710.
-
2CHUNG K F.The complementary role of glucocorticocorticosteroids and long-acting beta2-adrenergic agonists[J].Allergy,1998,53(42 suppl):7-13.
-
3EICKELBERY O,ROTH M,LORX,et al.Ligand-independent activation of the glucocorticoid receptor by b2-adrenergic receptor antagonists in primary human lung fibroblasts and vascular smooth muscle cells[J].J Biol Mol Chem,1999,274(2):1005-1010.
-
4SHREWSBURY S B,PYKE S D,BIRTTON M.A meta-analysis of increasing inhaled steroid or adding salmeterol in symp tomatic asthma[J].Br Med J,2000,320:1368-1373.
-
5Johnson M. The beta - adrenoceptor JI. Am J Respir Crit Care Med, 1998,158(5):146-153.
-
6GreenSA, Spasoff AP, Coleman RA, et al. Sustained activation of a protein - coupled receptor via anchored agonist binding. Molecular localization of the salmeterol exosite within the 2 - adrenergic receptor,J Biol chem,1996,271 :24 029-24 035.
-
7Eickelberg O, Roth M, lorx R, et al. Ligand - independent activation of the glucocorticoid receptor by beta 2 - adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem, 1999,274:1 005-1 010.
-
8Famer P,Pugin J.Beta-adrenergic agonists exert their"antiinflammation" effects in monocytic cells through the IKB/NF-κb pathway.Am J Physiol Lung Cell Mol Physiol,2000,279:1675-1682.
-
9儿童哮喘防治常规(试行)[J].中华儿科杂志,1998,36(12):747-751. 被引量:2373
-
10钟南山,郑劲平,刘晓青,肖正伦,姚婉贞,韩翔,王虹,柳小芳,孙铁英,方保民,缪竟智,王厚东,洪军,柯会兴,张洪胜,钮善福,李善群,顾宇彤,胡洁,张志凤,陈琪,钱桂生,王长征,孙鲲,赵志强,王金平,周泽云.吸入沙美特罗替卡松干粉剂与联合吸入两种干粉剂治疗成人哮喘的疗效和安全性的对照研究[J].中华结核和呼吸杂志,2002,25(6):371-374. 被引量:137
-
1陈素婷.噻托溴铵联合大剂量沙美特罗/替卡松治疗中重度慢性阻塞性肺疾病稳定期患者的疗效观察[J].当代医学,2015,21(1):119-120. 被引量:6
-
2王磊.舒利迭治疗支气管哮喘87例临床观察[J].四川医学,2012,33(10):1790-1791.
-
3王世礼.咳嗽变异性哮喘的临床诊断分析[J].求医问药(下半月),2013(1):460-461.
-
4童皖宁,卓安山,曹玉书,徐世林.BiPAP联合舒利迭对AECOPD合并Ⅱ型呼吸衰竭老年患者的疗效观察[J].临床肺科杂志,2013,18(6):1057-1060. 被引量:16
-
5洪旭华.噻托溴铵联合沙美特罗替卡松治疗慢性阻塞性肺疾病的临床疗效观察[J].中国社区医师,2015,31(8):37-37. 被引量:4
-
6陈明勇,陈斌,刘小英,徐维国,朱静.吸入沙美特罗/替卡松粉剂对稳定期COPD患者血清visfatin浓度的影响[J].西部医学,2014,26(2):186-188. 被引量:2
-
7徐鸿.沙美特罗/福替卡松对中重度慢性阻塞性肺疾病患者稳定期的临床疗效观察[J].中国医药指南,2013,11(23):622-623. 被引量:8
-
8谭正强.孟鲁斯特联合沙美特罗/替卡松治疗咳嗽变异性哮喘的临床观察[J].世界最新医学信息文摘,2015,15(26). 被引量:1
-
9郑喜文,杨建民,陶秀林.孟鲁司特钠联合舒利迭在支气管哮喘急性发作期的疗效观察[J].现代诊断与治疗,2015,26(14):3174-3175. 被引量:9
-
10古辉,徐小彭,钟获华.沙美特罗/福替卡松对中重度慢阻肺患者稳定期的疗效观察[J].北华大学学报(自然科学版),2014,15(2):225-228. 被引量:16